🇺🇸 FDA
Patent

US 10532109

Peptide-DNA chimeras for treatment of HER overexpressing cancers

granted A61KA61K38/00A61K38/16

Quick answer

US patent 10532109 (Peptide-DNA chimeras for treatment of HER overexpressing cancers) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/00, A61K38/16, A61K47/6807, A61K47/6851